Jean-Luc Lemercier
Net Worth

Last updated:

What is Jean-Luc Lemercier net worth?

The estimated net worth of Mr. Jean-Luc Lemercier is at least $34,401,416 as of 9 May 2023. He owns shares worth $13,808,421 as insider, has earned $12,682,995 from insider trading and has received compensation worth at least $7,910,000 in Edwards Lifesciences Corporation.

What is the salary of Jean-Luc Lemercier?

Mr. Jean-Luc Lemercier salary is $1,130,000 per year as Corporation Vice President of Europe, Middle East, Africa, Canada & Latin America in Edwards Lifesciences Corporation.

How old is Jean-Luc Lemercier?

Mr. Jean-Luc Lemercier is 68 years old, born in 1957.

What stocks does Jean-Luc Lemercier currently own?

As insider, Mr. Jean-Luc Lemercier owns shares in one company:

Company Title Shares Price per share Total value
Edwards Lifesciences Corporation (EW) Corporation Vice President of Europe, Middle East, Africa, Canada & Latin America 172,089 $80.24 $13,808,421

What does Edwards Lifesciences Corporation do?

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

EW logo
EW
Edwards Lifesciences Corporation
$80.24

Jean-Luc Lemercier insider trading

Edwards Lifesciences Corporation

Mr. Jean-Luc Lemercier has made 25 insider trades between 2018-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 23,120 units of EW stock on 9 May 2022. As of 9 May 2023 he still owns at least 172,089 units of EW stock.

Transaction Date Security Shares Price per share Total value Source
Option
Employee Stock Option (Right to Acquire) 6,640 $35.2 $233,708
Sale
Common Stock 6,640 $88.68 $588,835
Option
Common Stock 6,640 $35.2 $233,708
Option
Common Stock 6,640 $35.2 $233,708
Sale
Common Stock 6,640 $83.1 $551,764
Option
Employee Stock Option (Right to Acquire) 6,640 $35.2 $233,708
Option
Common Stock 6,640 $35.2 $233,708
Sale
Common Stock 6,590 $76.95 $507,127
Sale
Common Stock 50 $77.43 $3,872
Option
Employee Stock Option (Right to Acquire) 6,640 $35.2 $233,708
Sale
Common Stock 11,560 $98.25 $1,135,712
Option
Common Stock 11,560 $21.76 $251,546
Option
Employee Stock Option (Right to Acquire) 23,120 $21.76 $503,091
Option
Common Stock 8,531 N/A N/A
Sale
Common Stock 100 $123.57 $12,357
Sale
Common Stock 11,560 $123.29 $1,425,267
Option
Employee Stock Option (Right to Acquire) 11,660 $21.76 $253,722
Option
Common Stock 11,660 $21.76 $253,722
Option
Employee Stock Option (Right to Acquire) 11,660 $21.76 $253,722
Sale
Common Stock 6,535 $105.65 $690,410
Sale
Common Stock 5,125 $106.47 $545,664
Option
Common Stock 11,660 $21.76 $253,722
Sale
Common Stock 100 $110.58 $11,058
Option
Employee Stock Option (Right to Acquire) 100 $21.76 $2,176
Option
Common Stock 100 $21.76 $2,176
Option
Common Stock 10,631 N/A N/A
Option
Performance Rights 10,631 N/A N/A
Sale
Common Stock 13,020 $13.98 $182,020
Option
Employee Stock Option (Right to Acquire) 13,020 $13.98 $182,020
Option
Common Stock 13,020 $13.98 $182,020
Option
Common Stock 13,020 $13.98 $182,020
Option
Employee Stock Option (Right to Acquire) 13,020 N/A N/A
Sale
Common Stock 13,020 $84.85 $1,104,708
Sale
Common Stock 13,020 $42.29 $550,616
Option
Employee Stock Option (Right to Acquire) 20,523 $5.68 $116,468
Option
Common Stock 20,523 $12.67 $259,924
Sale
Common Stock 20,523 $83.51 $1,713,794
Option
Common Stock 20,523 $12.67 $259,924
Sale
Common Stock 20,523 $91.24 $1,872,477
Option
Common Stock 20,523 $5.68 $116,468
Option
Employee Stock Option (Right to Acquire) 20,523 $12.67 $259,924
Option
Performance Rights 3,587 N/A N/A
Option
Common Stock 3,587 N/A N/A
Sale
Common Stock 3,470 $35.79 $124,174
Option
Employee Stock Option (Right to Acquire) 3,470 $35.79 $124,174
Option
Common Stock 3,470 $35.79 $124,174
Option
Common Stock 3,470 $35.79 $124,174
Sale
Common Stock 3,470 $35.79 $124,174
Option
Employee Stock Option (Right to Acquire) 3,470 $35.79 $124,174
Sale
Common Stock 3,470 $35.79 $124,174
Option
Common Stock 3,470 $35.79 $124,174
Option
Employee Stock Option (Right to Acquire) 3,470 $35.79 $124,174
Option
Common Stock 3,470 $35.79 $124,174
Option
Employee Stock Option (Right to Acquire) 3,470 $35.79 $124,174
Sale
Common Stock 3,470 $35.79 $124,174
Option
Common Stock 4,188 $42.73 $178,932
Option
Employee Stock Option (Right to Acquire) 4,188 $42.73 $178,932
Sale
Common Stock 4,188 $42.73 $178,932
Option
Common Stock 4,186 $42.73 $178,847
Sale
Common Stock 4,186 $42.73 $178,847
Option
Employee Stock Option (Right to Acquire) 4,186 $42.73 $178,847
Option
Common Stock 4,186 $42.73 $178,847
Sale
Common Stock 4,186 $42.73 $178,847
Option
Employee Stock Option (Right to Acquire) 4,186 $42.73 $178,847
Sale
Common Stock 5,634 $44.62 $251,361
Option
Common Stock 5,634 $44.62 $251,361
Option
Employee Stock Option (Right to Acquire) 5,634 $44.62 $251,361
Option
Common Stock 5,633 $44.62 $251,316
Sale
Common Stock 5,633 $44.62 $251,316
Option
Employee Stock Option (Right to Acquire) 5,633 $44.62 $251,316
Sale
Common Stock 5,633 $44.62 $251,316
Option
Common Stock 5,633 $44.62 $251,316
Option
Employee Stock Option (Right to Acquire) 5,633 $44.62 $251,316

Edwards Lifesciences key executives

Edwards Lifesciences Corporation executives and other stock owners filed with the SEC: